Risk management and pharmacovigilance in non-medical prescribing decisions
Risk management and pharmacovigilance in non-medical prescribing decisions
Mather, Linda; Maw, Gillian
2017-09-02 00:00:00
This is the final article in a series of three in which the authors have discussed non-medical prescribing in the context of the law and explored how it applies to the field of aesthetic medicine. The aim of this article is to educate aesthetic practitioners about minimising risks associated with prescribing. The authors will consider the elements of prescribing risk, discuss common drug errors and outline the main types of adverse drug reactions.
http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.pngJournal of Aesthetic NursingMark Allen Grouphttp://www.deepdyve.com/lp/mark-allen-group/risk-management-and-pharmacovigilance-in-non-medical-prescribing-AW3gIKYN2K
Risk management and pharmacovigilance in non-medical prescribing decisions
This is the final article in a series of three in which the authors have discussed non-medical prescribing in the context of the law and explored how it applies to the field of aesthetic medicine. The aim of this article is to educate aesthetic practitioners about minimising risks associated with prescribing. The authors will consider the elements of prescribing risk, discuss common drug errors and outline the main types of adverse drug reactions.
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.